Striatisporolide A
Striatisporolide A is an antibacterial agent. Striatisporolide A exhibits antibacterial activity against Escherichia coli in vitro. Striatisporolide A damages the cell wall and cell membrane of Escherichia coli, and induces changes in protein levels and morphology. Striatisporolide A reduces the level of apoptosis (apoptosis) in HUVECs, inhibits excessive production of ROS, and possesses pro-proliferative and mild cytoprotective effects. Striatisporolide A can be used in studies related to bacterial infections and degenerative diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 851278-60-9
- Formel: C11H16O4
- Molecular Weight:212.24
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
Striatisporolide A (0-400 µM; 24 h) exhibits mild antibacterial activity against Escherichia coli ATCC 8739. After 24 h of incubation, the maximum growth inhibition rates reach 32.74% at 200 µM and 31.24% at 400 µM[1].
Striatisporolide A (200-400 µM; 20 h) produces small inhibition zones against Escherichia coli ATCC 8739 in the disk diffusion assay (7.03 mm at 200 µM and 7.08 mm at 400 µM)[1].
Striatisporolide A (200-400 µM; 0-24 h) disrupts the cell wall of Escherichia coli ATCC 8739 and increases extracellular AKP activity[1].
Striatisporolide A (200-400 µM; 0-2 h) rapidly disrupts the cell membrane of Escherichia coli ATCC 8739 and induces ATP leakage, which reaches a peak at 0.5 h: the ATP level is 0.83 µM in the 200 µM treatment group and 0.96 µM in the 400 µM treatment group[1].
Striatisporolide A (200-400 µM; 24-32 h) alters protein expression in Escherichia coli ATCC 8739: after incubation at 200 or 400 µM for 24 or 32 h, it increases the level of the 35 kDa protein in aqueous suspensions and decreases the level of the 10 kDa protein in lysates[1].
Striatisporolide A (200-400 µM; 20 h) induces morphological changes in Escherichia coli ATCC 8739. After incubation at 200 or 400 µM for 20 h, the strain exhibits rough cell surfaces, irregular sizes and shortened lengths[1].
Striatisporolide A (200-400 µM; 24 h) disrupts the ultrastructure of Escherichia coli ATCC 8739 and induces abnormal cell morphology after 24 h of incubation at concentrations of 200 or 400 µM[1].
Striatisporolide A (0-150 μM; 48 h) promotes the proliferation of human umbilical vein endothelial cells (HUVECs), with the peak effect observed at 100 μM, which increases cell viability to 128.72%[2].
Striatisporolide A (0-150 μM; 48 h pre-incubation prior to 40 min H2O2 exposure) exerts cytoprotective activity against H2O2-induced oxidative damage in human umbilical vein endothelial cells (HUVECs), and pre-incubation at a concentration of 50 μM increases the cell survival rate to 56.94%[2].
Striatisporolide A (100 μM; 48 h) inhibits apoptosis of HUVECs under basal conditions and after H2O2-induced oxidative stress, reducing the apoptosis rate to 2.17% and 3.1%, respectively, at the concentration of 100 μM[2].
Striatisporolide A (50-150 μM; pre-incubated for 48 h prior to 40 min of H2O2 exposure) inhibits excessive intracellular ROS production induced by H2O2 in HUVECs, reducing the fluorescence intensity to 9.47 at a concentration of 100 μM[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HUVECs
-
Concentration:0 μM; 25 μM; 50 μM; 100 μM; 150 μM
-
Incubation Time:48 h
-
Result:Increased cell viability over 100% in a dose-dependent manner between 25 μM and 100 μM.
Increased cell viability to 128.72% compared to the control group at 100 μM (p < 0.05).
Decreased cell viability to 99.76% compared to the control group at 150 μM.
-
Cell Line:HUVECs
-
Concentration:25 μM; 50 μM; 100 μM; 150 μM
-
Incubation Time:48 h (pre-incubation) prior to 40 min H2O2 exposure
-
Result:Enhanced cell viability to 56.94% compared to the H2O2-only group at 50 μM (p < 0.01).
Showed no dose-response relationship in H2O2-treated cells.
-
Cell Line:HUVECs
-
Concentration:100 μM
-
Incubation Time:48 h (alone); 48 h prior to 40 min H2O2 exposure
-
Result:Reduced the apoptosis rate to 2.17% compared to the control group (8.57%) under non-H2O2-treated conditions.
Reduced the apoptosis rate to 3.1% compared to the H2O2-only group (10.13%) under H2O2-treated conditions.
Chemical Information
-
CAS. Nr. 851278-60-9
-
Molecular Weight 212.24
-
Formel C11H16O4
-
SMILES
CCCCC[C@H]1C(C(O)=O)=C(C(O1)=O)C
-
Structure Classification
-
Initial Source
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Reinheit & Dokumentation
Verweise
[1]. Sheng JW, et al. Striatisporolide A, a butenolide metabolite from Athyrium multidentatum (Doll.) Ching, as a potential antibacterial agent. Mol Med Rep. 2019;20(1):198-204. [Content Brief]
[2]. Liu DM, et al. Cytoproliferative and Cytoprotective Effects of Striatisporolide A Isolated from Rhizomes of Athyrium multidentatum (Doell.) Ching on Human Umbilical Vein Endothelial Cells. Molecules. 2016;21(10):1280. Published 2016 Sep 24. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- Striatisporolide A
- 851278-60-9
- Bacterial
- Apoptosis
- Reactive Oxygen Species (ROS)
- HUVECs
- Penicillium janthinellum
- Athyrium multidentatum
- human umbilical vein endothelial cells
- Penicillium striatisporum
- Escherichia coli ATCC 8739
- escherichia coli infection
- ROS
- Escherichia coli
- reactive oxygen species
- Inhibitor
- inhibitor
- inhibit